127 research outputs found
Orion\u27s Veil: Magnetic Field Strengths and Other Properties of a PDR in Front of the Trapezium Cluster
We present an analysis of physical conditions in the Orion Veil, an atomic photon-dominated region (PDR) that lies just in front (≈2 pc) of the Trapezium stars of Orion. This region offers an unusual opportunity to study the properties of PDRs, including the magnetic field. We have obtained 21 cm H i and 18 cm (1665 and 1667 MHz) OH Zeeman effect data that yield images of the line-of-sight magnetic field strength B los in atomic and molecular regions of the Veil. We find B los ≈ −50 to −75 μG in the atomic gas across much of the Veil (25\u27\u27 resolution) and B los ≈ −350 μG at one position in the molecular gas (40\u27\u27 resolution). The Veil has two principal H i velocity components. Magnetic and kinematical data suggest a close connection between these components. They may represent gas on either side of a shock wave preceding a weak-D ionization front. Magnetic fields in the Veil H i components are 3–5 times stronger than they are elsewhere in the interstellar medium where N(H) and n(H) are comparable. The H i components are magnetically subcritical (magnetically dominated), like the cold neutral medium, although they are about 1 dex denser. Comparatively strong fields in the Veil H i components may have resulted from low-turbulence conditions in the diffuse gas that gave rise to OMC-1. Strong fields may also be related to magnetostatic equilibrium that has developed in the Veil since star formation. We also consider the location of the Orion-S molecular core, proposing a location behind the main Orion H+ region
A Magnetically Supported Photodissociation Region in M17
The southwestern (SW) part of the Galactic H II region M17 contains an obscured ionization front that is most easily seen at infrared and radio wavelengths. It is nearly edge-on, thus offering an excellent opportunity to study the way in which the gas changes from fully ionized to molecular as radiation from the ionizing stars penetrates into the gas. M17 is also one of the very few H II regions for which the magnetic field strength can be measured in the photodissociation region ( PDR) that forms the interface between the ionized and molecular gas. Here we model an observed line of sight through the gas cloud, including the H+, H0 (PDR), and molecular layers, in a fully self-consistent single calculation. An interesting aspect of the M17 SW bar is that the PDR is very extended. We show that the strong magnetic field that is observed to be present inevitably leads to a very deep PDR, because the structure of the neutral and molecular gas is dominated by magnetic pressure, rather than by gas pressure, as previously had been supposed. We also show that a wide variety of observed facts can be explained if a hydrostatic geometry prevails, in which the gas pressure from an inner X-ray hot bubble and the outward momentum of the stellar radiation field compress the gas and its associated magnetic field in the PDR, as has already been shown to occur in the Orion Nebula. The magnetic field compression may also amplify the local cosmic-ray density. The pressure in the observed magnetic field balances the outward forces, suggesting that the observed geometry is a natural consequence of the formation of a star cluster within a molecular cloud
Perspectives on Astrophysics Based on Atomic, Molecular, and Optical (AMO) Techniques
About two generations ago, a large part of AMO science was dominated by
experimental high energy collision studies and perturbative theoretical
methods. Since then, AMO science has undergone a transition and is now
dominated by quantum, ultracold, and ultrafast studies. But in the process, the
field has passed over the complexity that lies between these two extremes. Most
of the Universe resides in this intermediate region. We put forward that the
next frontier for AMO science is to explore the AMO complexity that describes
most of the Cosmos.Comment: White paper submission to the Decadal Assessment and Outlook Report
on Atomic, Molecular, and Optical (AMO) Science (AMO 2020
A Spitzer Space Telescope Infrared Survey of Supernova Remnants in the Inner Galaxy
Using Infrared Array Camera (IRAC) images at 3.6, 4.5, 5.8, and 8 microns
from the GLIMPSE Legacy science program on the Spitzer Space Telescope, we
searched for infrared counterparts to the 95 known supernova remnants that are
located within galactic longitudes 65>|l|>10 degrees and latitudes |b|<1
degree. Eighteen infrared counterparts were detected. Many other supernova
remnants could have significant infrared emission but are in portions of the
Milky Way too confused to allow separation from bright HII regions and
pervasive mid-infrared emission from atomic and molecular clouds along the line
of sight. Infrared emission from supernova remnants originates from synchrotron
emission, shock-heated dust, atomic fine-structure lines, and molecular lines.
The detected remnants are G11.2-0.3, Kes 69, G22.7-0.2, 3C 391, W 44, 3C 396,
3C 397, W 49B, G54.4-0.3, Kes 17, Kes 20A, RCW 103, G344.7-0.1, G346.6-0.2, CTB
37A, G348.5-0.0, and G349.7+0.2. The infrared colors suggest emission from
molecular lines (9 remnants), fine-structure lines (3), and PAH (4), or a
combination; some remnants feature multiple colors in different regions. None
of the remnants are dominated by synchrotron radiation at mid-infrared
wavelengths. The IRAC-detected sample emphasizes remnants interacting with
relatively dense gas, for which most of the shock cooling occurs through
molecular or ionic lines in the mid-infrared.Comment: Accepted 10/18/2005 for publication in "The Astronomical Journal".
The figures in this astro-ph submission are drastically reduced in quality in
order to fit within its limit
G64.5+0.9, a new shell supernova remnant with unusual central emission
We present observations between 1.4 and 18 GHz confirming that G64.5+0.9 is
new Galactic shell supernova remnant, using the Very Large Array and the
Arcminute Microkelvin Imager. The remnant is a shell ~8 arcmin in diameter with
a spectral index of alpha = 0.47 +/- 0.03 (with alpha defined such that flux
density S varies with frequency nu as S proportional to nu to the power of
-alpha). There is also emission near the centre of the shell, ~1 arcmin in
extent, with a spectral index of alpha = 0.81 +/- 0.02. We do not find any
evidence for spectral breaks for either source within our frequency range. The
nature of the central object is unclear and requires further investigation, but
we argue that is most unlikely to be extragalactic. It is difficult to avoid
the conclusion that it is associated with the shell, although its spectrum is
very unlike that of known pulsar wind nebulae.Comment: 5 pages, 6 figures, submitted to MNRA
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target
Adamantinomatous craniopharyngiomas (ACPs) are clinically challenging tumours, the majority of which have activating mutations in CTNNB1. They are histologically complex, showing cystic and solid components, the latter comprised of different morphological cell types (e.g. β-catenin-accumulating cluster cells and palisading epithelium), surrounded by a florid glial reaction with immune cells. Here, we have carried out RNA sequencing on 18 ACP samples and integrated these data with an existing ACP transcriptomic dataset. No studies so far have examined the patterns of gene expression within the different cellular compartments of the tumour. To achieve this goal, we have combined laser capture microdissection with computational analyses to reveal groups of genes that are associated with either epithelial tumour cells (clusters and palisading epithelium), glial tissue or immune infiltrate. We use these human ACP molecular signatures and RNA-Seq data from two ACP mouse models to reveal that cell clusters are molecularly analogous to the enamel knot, a critical signalling centre controlling normal tooth morphogenesis. Supporting this finding, we show that human cluster cells express high levels of several members of the FGF, TGFB and BMP families of secreted factors, which signal to neighbouring cells as evidenced by immunostaining against the phosphorylated proteins pERK1/2, pSMAD3 and pSMAD1/5/9 in both human and mouse ACP. We reveal that inhibiting the MAPK/ERK pathway with trametinib, a clinically approved MEK inhibitor, results in reduced proliferation and increased apoptosis in explant cultures of human and mouse ACP. Finally, we analyse a prominent molecular signature in the glial reactive tissue to characterise the inflammatory microenvironment and uncover the activation of inflammasomes in human ACP. We validate these results by immunostaining against immune cell markers, cytokine ELISA and proteome analysis in both solid tumour and cystic fluid from ACP patients. Our data support a new molecular paradigm for understanding ACP tumorigenesis as an aberrant mimic of natural tooth development and opens new therapeutic opportunities by revealing the activation of the MAPK/ERK and inflammasome pathways in human ACP.
KEYWORDS:
Craniopharyngioma; IL1-β; Inflammasome; MAPK/ERK pathway; Odontogenesis; Paracrine signalling; Trametini
iGEMS : an integrated model for identification of alternative exon usage events
DNA microarrays and RNAseq are complementary methods for studying RNA molecules. Current computational methods to determine alternative exon usage (AEU) using such data require impractical visual inspection and still yield high false-positive rates. Integrated Gene and Exon Model of Splicing (iGEMS) adapts a gene-level residuals model with a gene size adjusted false discovery rate and exon-level analysis to circumvent these limitations. iGEMS was applied to two new DNA microarray datasets, including the high coverage Human Transcriptome Arrays 2.0 and performance was validated using RT-qPCR. First, AEU was studied in adipocytes treated with (n = 9) or without (n = 8) the anti-diabetes drug, rosiglitazone. iGEMS identified 555 genes with AEU, and robust verification by RT-qPCR (similar to 90%). Second, in a three-way human tissue comparison (muscle, adipose and blood, n = 41) iGEMS identified 4421 genes with at least one AEU event, with excellent RT-qPCR verification (95%, n = 22). Importantly, iGEMS identified a variety of AEU events, including 3'UTR extension, as well as exon inclusion/exclusion impacting on protein kinase and extracellular matrix domains. In conclusion, iGEMS is a robust method for identification of AEU while the variety of exon usage between human tissues is 5-10 times more prevalent than reported by the Genotype-Tissue Expression consortium using RNA sequencing.Peer reviewe
- …